West Pharmaceutical Services Inc (WST)
219.97
-1.53
(-0.69%)
USD |
NYSE |
Apr 03, 16:00
220.00
+0.03
(+0.01%)
After-Hours: 16:32
West Pharmaceutical Services Enterprise Value: 15.73B for April 2, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 386.51B |
| Moderna Inc | 3.692B |
| Gilead Sciences Inc | 154.40B |
| Zoetis Inc | 77.80B |
| Vertex Pharmaceuticals Inc | 118.04B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 130.10M |
| Revenue (Quarterly) | 748.80M |
| Total Expenses (Quarterly) | 579.00M |
| EPS Diluted (Quarterly) | 1.78 |
| Gross Profit Margin (Quarterly) | 36.54% |
| Profit Margin (Quarterly) | 17.37% |
| Earnings Yield | 3.04% |
| Operating Earnings Yield | 3.64% |
| Normalized Earnings Yield | 3.141 |